bf/NASDAQ:SUPN_icon.jpeg

COM:SUPERNUS

Supernus Pharmaceuticals

  • Stock

Last Close

35.82

22/11 21:00

Market Cap

2.00B

Beta: -

Volume Today

190.74K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
12.02M
-
122.05M
915.43%
144.43M
18.34%
215.00M
48.87%
302.24M
40.57%
408.90M
35.29%
392.75M
3.95%
520.40M
32.50%
579.77M
11.41%
667.24M
15.09%
607.52M
8.95%
cost of revenue
1.10M
-
5.76M
421.56%
8.42M
46.28%
11.99M
42.30%
15.21M
26.94%
15.36M
0.93%
16.66M
8.49%
52.46M
214.88%
75.06M
43.09%
87.22M
16.20%
168.64M
93.35%
gross profit
10.91M
-
116.29M
965.39%
136.00M
16.96%
203.02M
49.27%
287.02M
41.38%
393.54M
37.11%
376.10M
4.43%
467.94M
24.42%
504.71M
7.86%
580.02M
14.92%
438.88M
24.33%
selling and marketing expenses
134.75M
-
199.71M
48.20%
267.79M
34.09%
229.19M
14.42%
general and administrative expenses
65.92M
-
105.05M
59.35%
109.43M
4.17%
107.17M
2.06%
selling general and administrative expenses
55.59M
-
72.47M
30.37%
89.20M
23.09%
106.01M
18.84%
137.91M
30.09%
159.89M
15.94%
158.43M
0.92%
200.68M
26.67%
304.76M
51.87%
377.22M
23.78%
336.36M
10.83%
research and development expenses
17.25M
-
19.59M
13.57%
29.14M
48.75%
42.79M
46.87%
49.58M
15.86%
89.21M
79.94%
69.10M
22.54%
75.96M
9.93%
90.47M
19.10%
74.55M
17.59%
89.12M
19.54%
other expenses
101K
-
39K
61.39%
38K
2.56%
-15K
139.47%
15.70M
-
29.99M
90.99%
82.63M
175.53%
cost and expenses
73.94M
-
97.81M
32.29%
126.76M
29.59%
160.79M
26.84%
202.70M
26.07%
264.45M
30.47%
244.18M
7.66%
344.80M
41.20%
500.28M
45.09%
621.62M
24.26%
594.12M
4.42%
operating expenses
72.83M
-
92.06M
26.39%
118.34M
28.55%
148.80M
25.74%
187.48M
26.00%
249.10M
32.86%
227.52M
8.66%
292.34M
28.49%
425.21M
45.45%
534.40M
25.68%
425.48M
20.38%
interest expense
7.85M
-
4.96M
36.77%
1.23M
75.24%
5.09M
314.24%
1.57M
69.20%
18.11M
1,055.04%
22.71M
25.38%
23.75M
4.61%
23.42M
1.39%
7.07M
69.82%
2.42M
65.84%
ebitda
-61.52M
-
24.62M
140.01%
18.35M
25.47%
55.68M
203.52%
102.41M
83.91%
158.29M
54.57%
170.19M
7.52%
210.00M
23.39%
120.06M
42.83%
149.93M
24.88%
98.26M
34.46%
operating income
-61.92M
-
24.23M
139.13%
17.66M
27.09%
54.22M
206.91%
99.54M
83.60%
144.44M
45.11%
148.57M
2.86%
173.70M
16.91%
86.03M
50.47%
67.30M
21.77%
13.40M
80.09%
depreciation and amortization
742K
-
928K
25.07%
921K
0.75%
2.40M
160.48%
8.13M
238.97%
7.06M
13.15%
21.62M
206.14%
36.31M
67.90%
34.03M
6.27%
82.63M
142.83%
84.86M
2.70%
total other income expenses net
-22.90M
-
217K
100.95%
-2.11M
1,070.97%
-238K
88.70%
-219K
7.98%
-4.27M
1,848.86%
-1.08M
74.60%
-5.05M
365.87%
-12.85M
154.53%
-6.56M
48.97%
-10.63M
62.10%
income before tax
-92.27M
-
19.87M
121.54%
14.97M
24.65%
50.37M
236.42%
100.62M
99.76%
140.18M
39.32%
147.49M
5.22%
168.65M
14.35%
73.17M
56.61%
60.74M
16.99%
2.77M
95.44%
income tax expense
7.11M
-
4.04M
43.22%
956K
76.31%
-40.85M
4,373.22%
43.33M
206.08%
29.18M
32.66%
34.43M
17.98%
41.70M
21.11%
19.75M
52.63%
32K
99.84%
1.45M
4,440.63%
net income
-92.27M
-
19.87M
121.54%
14.02M
29.47%
91.22M
550.83%
57.28M
37.20%
110.99M
93.76%
113.06M
1.86%
126.95M
12.29%
53.42M
57.92%
60.71M
13.64%
1.32M
97.83%
weighted average shs out
31.85M
-
42.26M
32.69%
47.49M
12.36%
49.47M
4.18%
50.76M
2.60%
51.99M
2.43%
52.41M
0.81%
52.62M
0.39%
53.10M
0.92%
53.67M
1.07%
54.54M
1.62%
weighted average shs out dil
31.85M
-
50.58M
58.83%
51.16M
1.14%
51.71M
1.07%
53.30M
3.08%
54.10M
1.50%
53.82M
0.52%
53.69M
0.24%
54.36M
1.24%
61.68M
13.47%
55.51M
10.01%
eps
-2.90
-
0.47
116.21%
0.29
38.30%
1.84
534.48%
1.13
38.59%
2.13
88.50%
2.16
1.41%
2.41
11.57%
1.01
58.09%
1.13
11.88%
0.02
97.87%
epsdiluted
-2.90
-
0.32
111.03%
0.28
12.50%
1.76
528.57%
1.08
38.64%
2.05
89.81%
2.10
2.44%
2.36
12.38%
0.98
58.47%
1.04
6.12%
0.02
97.72%

All numbers in (except ratios and percentages)